1Sellers DJ, McKay N. Developments in the phannacotherapy of the overactive bladder [J]. Curr Opin Urol, 2007, 17(4): 223-230.
2Lam S, Hilas O. Pharmacologic management of overactive bladder [J]. Clin Interv Aging, 2007, 2(3): 337-345.
3Hashim H, Abrams P. Overactive bladder: an update [J]. Curr Opin Urol, 2007,17(4): 231-236.
4Abrams P, Artibani W, Cardozo L, et al. Reviewing the ICS 2002 terminology report: The ongoing debate [J]. Neurourol Urodyn, 2006, 25 (3): 293.
5Hashim H, Abrams P. Is the bladder a reliable witness for predicting detrusor overactivity[J]? J Urol, 2006, 175(1): 191-195.
6Andersson KE, Appell R, Cardozo L, et al. Pharmacological treatment of urinary incontinence [M]. In: Abrams P, Cardozo L, Khoury S, et al, editors. Incontinence. 3rd International Consultation on Incontinence. Paris: Health Publication Ltd, 2005: 809-854.
7Flisser A J, Walmsley K, Blaivas JG. Urodynamic classification of patients with symptoms of overactive bladder [J]. J Urol, 2003, 169 (2): 529-534.
8Abrams P, Andersson KE, Brubaker L, et al. Recommendations of the International Scientific Committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse and faecal incontinence [M]. In: Abrams P, Cardozo L, Khoury S, et al., editors. Incontinence. 3rd International Consultation on Incontinence. Paris: Health Publication Ltd, 2005: 1589-1630.
9Nowara A, Witek A, Wilk K. Diagnostic and treatment of overactive bladder [J]. Ginekol Pol, 2007, 78(7):549-553.
10Dmochowski RR, Sanders SW, Appell RA, et al. Bladder-health diaries: an assessment of 3-day vs 7-day entries [J]. BJU Int, 2005, 96(7): 1049-1054.
